See biobetter on Wiktionary
Download JSON data for biobetter meaning in All languages combined (2.5kB)
{
"etymology_templates": [
{
"args": {
"1": "en",
"2": "bio-",
"3": "better"
},
"expansion": "bio- + better",
"name": "af"
},
{
"args": {
"1": "en",
"2": "G. V. Prasad",
"nat": "Indian",
"nobycat": "1",
"occ": "business executive"
},
"expansion": "Coined by Indian business executive G. V. Prasad",
"name": "coinage"
}
],
"etymology_text": "From bio- + better. Coined by Indian business executive G. V. Prasad, managing director of Dr. Reddy's Laboratories, in 2007.",
"forms": [
{
"form": "biobetters",
"tags": [
"plural"
]
}
],
"head_templates": [
{
"args": {},
"expansion": "biobetter (plural biobetters)",
"name": "en-noun"
}
],
"lang": "English",
"lang_code": "en",
"pos": "noun",
"senses": [
{
"categories": [
{
"kind": "other",
"name": "English entries with incorrect language header",
"parents": [
"Entries with incorrect language header",
"Entry maintenance"
],
"source": "w"
},
{
"kind": "other",
"name": "English terms prefixed with bio-",
"parents": [],
"source": "w"
},
{
"kind": "topical",
"langcode": "en",
"name": "Pharmacology",
"orig": "en:Pharmacology",
"parents": [
"Biochemistry",
"Medicine",
"Biology",
"Chemistry",
"Sciences",
"All topics",
"Fundamental"
],
"source": "w"
}
],
"examples": [
{
"text": "Coordinate term: biosimilar"
},
{
"ref": "2016 February, Daniel Casey, “Key strategic factors for stakeholders in the current global biosimilar market”, in Drug Discovery Today, volume 21, number 2, →DOI, page 208",
"text": "In general, originators have short-term options available, such as patent litigation, but should focus on sustainable long-term strategies such as development of biobetters or incorporating biosimilars as complements to existing products.",
"type": "quotation"
}
],
"glosses": [
"A medication developed by modifying an approved biological drug to enhance its properties (e.g., improved efficacy, higher selectivity or lower toxicity)."
],
"id": "en-biobetter-en-noun-KGZSDduR",
"links": [
[
"pharmacology",
"pharmacology"
],
[
"medication",
"medication"
],
[
"develop",
"develop"
],
[
"modify",
"modify"
],
[
"approved",
"approved"
],
[
"biological",
"biological"
],
[
"drug",
"drug"
],
[
"enhance",
"enhance"
],
[
"properties",
"property"
],
[
"improved",
"improved"
],
[
"efficacy",
"efficacy"
],
[
"high",
"high"
],
[
"selectivity",
"selectivity"
],
[
"low",
"low"
],
[
"toxicity",
"toxicity"
]
],
"raw_glosses": [
"(pharmacology) A medication developed by modifying an approved biological drug to enhance its properties (e.g., improved efficacy, higher selectivity or lower toxicity)."
],
"topics": [
"medicine",
"pharmacology",
"sciences"
],
"wikipedia": [
"Dr. Reddy's Laboratories"
]
}
],
"word": "biobetter"
}
{
"etymology_templates": [
{
"args": {
"1": "en",
"2": "bio-",
"3": "better"
},
"expansion": "bio- + better",
"name": "af"
},
{
"args": {
"1": "en",
"2": "G. V. Prasad",
"nat": "Indian",
"nobycat": "1",
"occ": "business executive"
},
"expansion": "Coined by Indian business executive G. V. Prasad",
"name": "coinage"
}
],
"etymology_text": "From bio- + better. Coined by Indian business executive G. V. Prasad, managing director of Dr. Reddy's Laboratories, in 2007.",
"forms": [
{
"form": "biobetters",
"tags": [
"plural"
]
}
],
"head_templates": [
{
"args": {},
"expansion": "biobetter (plural biobetters)",
"name": "en-noun"
}
],
"lang": "English",
"lang_code": "en",
"pos": "noun",
"senses": [
{
"categories": [
"English coinages",
"English countable nouns",
"English entries with incorrect language header",
"English lemmas",
"English nouns",
"English terms prefixed with bio-",
"English terms with quotations",
"en:Pharmacology"
],
"examples": [
{
"text": "Coordinate term: biosimilar"
},
{
"ref": "2016 February, Daniel Casey, “Key strategic factors for stakeholders in the current global biosimilar market”, in Drug Discovery Today, volume 21, number 2, →DOI, page 208",
"text": "In general, originators have short-term options available, such as patent litigation, but should focus on sustainable long-term strategies such as development of biobetters or incorporating biosimilars as complements to existing products.",
"type": "quotation"
}
],
"glosses": [
"A medication developed by modifying an approved biological drug to enhance its properties (e.g., improved efficacy, higher selectivity or lower toxicity)."
],
"links": [
[
"pharmacology",
"pharmacology"
],
[
"medication",
"medication"
],
[
"develop",
"develop"
],
[
"modify",
"modify"
],
[
"approved",
"approved"
],
[
"biological",
"biological"
],
[
"drug",
"drug"
],
[
"enhance",
"enhance"
],
[
"properties",
"property"
],
[
"improved",
"improved"
],
[
"efficacy",
"efficacy"
],
[
"high",
"high"
],
[
"selectivity",
"selectivity"
],
[
"low",
"low"
],
[
"toxicity",
"toxicity"
]
],
"raw_glosses": [
"(pharmacology) A medication developed by modifying an approved biological drug to enhance its properties (e.g., improved efficacy, higher selectivity or lower toxicity)."
],
"topics": [
"medicine",
"pharmacology",
"sciences"
],
"wikipedia": [
"Dr. Reddy's Laboratories"
]
}
],
"word": "biobetter"
}
This page is a part of the kaikki.org machine-readable All languages combined dictionary. This dictionary is based on structured data extracted on 2024-06-19 from the enwiktionary dump dated 2024-06-06 using wiktextract (372f256 and 664a3bc). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.
If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.